COMPOSITION AND METHOD FOR TREATING GLOMERULONEPHRITIS AND OTHER INFLAMMATORY DISEASES

PROBLEM TO BE SOLVED: To provide a new approach for reducing glomerular inflammation and renal dysfunction associated with glomerulonephritis (GN).SOLUTION: There are provided: a nucleic acid molecule comprising a nucleotide sequence encoding scFv polypeptide containing a specific amino acid sequenc...

Full description

Saved in:
Bibliographic Details
Main Authors SQUINTO STEPHEN P, NYE STEVEN H, EVANS MARK J, MATIS LOUIS, WANG YI, THOMAS THOMAS C, SPRINGHORN JEREMY P, ROLLINS SCOTT, WILKINS JAMES A, MUELLER EILEEN ELLIOTT, ROTHER RUSSELL P
Format Patent
LanguageEnglish
Published 24.05.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide a new approach for reducing glomerular inflammation and renal dysfunction associated with glomerulonephritis (GN).SOLUTION: There are provided: a nucleic acid molecule comprising a nucleotide sequence encoding scFv polypeptide containing a specific amino acid sequence; a nucleic acid molecule comprising a nucleotide sequence encoding polypeptide containing a specific variable light chain region amino acid sequence corresponding to amino acid 3 to amino acid 110; a nucleic acid molecule comprising a nucleotide sequence encoding polypeptide containing a specific variable heavy chain region amino acid sequence corresponding to amino acid 1 to amino acid 122; or an isolated protein comprising (a) a first polypeptide region containing a specific variable light chain region amino acid sequence corresponding to amino acid 3 to amino acid 110 and (b) a second polypeptide region containing a specific variable heavy chain region amino acid sequence corresponding to amino acid 1 to amino acid 122.
Bibliography:Application Number: JP20110248008